CHEMBIO DIAGNOSTICS INC (CEMI) Fundamental Analysis & Valuation

NASDAQ:CEMI • US1635722093

Current stock price

0.455 USD
+0 (+0.22%)
At close:
0.4311 USD
-0.02 (-5.25%)
After Hours:

This CEMI fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

0

1. CEMI Profitability Analysis

1.1 Basic Checks

  • CEMI had negative earnings in the past year.
  • CEMI had a negative operating cash flow in the past year.
CEMI Yearly Net Income VS EBIT VS OCF VS FCFCEMI Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 -10M -20M -30M

1.2 Ratios

  • CEMI has negative profitability rations, so we won't be analyzing them here.
Industry RankSector Rank
ROA N/A
ROE N/A
ROIC N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
CEMI Yearly ROA, ROE, ROICCEMI Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 -20 -40 -60 -80 -100

1.3 Margins

  • The Gross Margin of CEMI (22.10%) is worse than 78.20% of its industry peers.
  • CEMI's Gross Margin has declined in the last couple of years.
  • The Profit Margin and Operating Margin are not available for CEMI so they could not be analyzed.
Industry RankSector Rank
OM N/A
PM (TTM) N/A
GM 22.1%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.23%
GM growth 5Y-13.7%
CEMI Yearly Profit, Operating, Gross MarginsCEMI Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 0 20 -20 40 -40 -60

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

2

2. CEMI Health Analysis

2.1 Basic Checks

  • CEMI does not have a ROIC to compare to the WACC, probably because it is not profitable.
  • CEMI has more shares outstanding than it did 1 year ago.
  • The debt/assets ratio for CEMI is higher compared to a year ago.
CEMI Yearly Shares OutstandingCEMI Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M
CEMI Yearly Total Debt VS Total AssetsCEMI Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 20M 40M 60M

2.2 Solvency

  • Based on the Altman-Z score of -3.34, we must say that CEMI is in the distress zone and has some risk of bankruptcy.
  • CEMI has a Altman-Z score of -3.34. This is in the lower half of the industry: CEMI underperforms 65.40% of its industry peers.
  • A Debt/Equity ratio of 0.00 indicates that CEMI is not too dependend on debt financing.
  • CEMI has a Debt to Equity ratio of 0.00. This is in the better half of the industry: CEMI outperforms 65.88% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Altman-Z -3.34
ROIC/WACCN/A
WACC9.13%
CEMI Yearly LT Debt VS Equity VS FCFCEMI Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 0 20M -20M

2.3 Liquidity

  • A Current Ratio of 1.23 indicates that CEMI should not have too much problems paying its short term obligations.
  • CEMI's Current ratio of 1.23 is on the low side compared to the rest of the industry. CEMI is outperformed by 82.94% of its industry peers.
  • A Quick Ratio of 1.04 indicates that CEMI should not have too much problems paying its short term obligations.
  • Looking at the Quick ratio, with a value of 1.04, CEMI is doing worse than 78.67% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 1.23
Quick Ratio 1.04
CEMI Yearly Current Assets VS Current LiabilitesCEMI Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M 50M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

2

3. CEMI Growth Analysis

3.1 Past

  • The Earnings Per Share has grown by an impressive 45.07% over the past year.
  • CEMI shows a small growth in Revenue. In the last year, the Revenue has grown by 3.57%.
  • The Revenue has been growing by 15.57% on average over the past years. This is quite good.
EPS 1Y (TTM)45.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.95%
Revenue 1Y (TTM)3.57%
Revenue growth 3Y12.85%
Revenue growth 5Y15.57%
Sales Q2Q%-49.72%

3.2 Future

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

  • No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
  • No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
CEMI Yearly Revenue VS EstimatesCEMI Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 10M 20M 30M 40M
CEMI Yearly EPS VS EstimatesCEMI Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 -0.2 -0.4 -0.6 -0.8 -1

More info and screens

Find the best growth stocksShow best growing peers

0

4. CEMI Valuation Analysis

4.1 Price/Earnings Ratio

  • CEMI reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Industry RankSector Rank
PE N/A
Fwd PE N/A
CEMI Price Earnings VS Forward Price EarningsCEMI Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 0 0 0 0 0 0 0 0 0 0

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
CEMI Per share dataCEMI EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 0.5 -0.5 1

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. CEMI Dividend Analysis

5.1 Amount

  • CEMI does not give a dividend.
Industry RankSector Rank
Dividend Yield N/A

More info and screens

Find the best dividend stocksShow peers with best dividend

CEMI Fundamentals: All Metrics, Ratios and Statistics

CHEMBIO DIAGNOSTICS INC

NASDAQ:CEMI (4/27/2023, 8:20:06 PM)

After market: 0.4311 -0.02 (-5.25%)

0.455

+0 (+0.22%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)03-09
Earnings (Next)05-09
Inst Owners0%
Inst Owner Change0%
Ins Owners7.8%
Ins Owner Change0%
Market Cap16.71M
Revenue(TTM)49.52M
Net Income(TTM)-23.29M
Analysts43.33
Price Target8.16 (1693.41%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)N/A
EPS NY rev (3m)N/A
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)N/A
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE N/A
Fwd PE N/A
P/S 0.34
P/FCF N/A
P/OCF N/A
P/B 0.94
P/tB 0.94
EV/EBITDA N/A
EPS(TTM)-0.75
EYN/A
EPS(NY)N/A
Fwd EYN/A
FCF(TTM)-0.39
FCFYN/A
OCF(TTM)-0.35
OCFYN/A
SpS1.35
BVpS0.48
TBVpS0.48
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
Industry RankSector Rank
ROA N/A
ROE N/A
ROCE N/A
ROIC N/A
ROICexc N/A
ROICexgc N/A
OM N/A
PM (TTM) N/A
GM 22.1%
FCFM N/A
ROA(3y)N/A
ROA(5y)N/A
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-14.23%
GM growth 5Y-13.7%
F-Score3
Asset Turnover0.79
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr 56.84%
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 1.23
Quick Ratio 1.04
Altman-Z -3.34
F-Score3
WACC9.13%
ROIC/WACCN/A
Cap/Depr(3y)91.56%
Cap/Depr(5y)127.18%
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)45.07%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%94.95%
EPS Next YN/A
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)3.57%
Revenue growth 3Y12.85%
Revenue growth 5Y15.57%
Sales Q2Q%-49.72%
Revenue Next YearN/A
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y15.04%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next YearN/A
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y56.8%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y58.9%
OCF growth 3YN/A
OCF growth 5YN/A

CHEMBIO DIAGNOSTICS INC / CEMI Fundamental Analysis FAQ

What is the ChartMill fundamental rating of CHEMBIO DIAGNOSTICS INC (CEMI) stock?

ChartMill assigns a fundamental rating of 2 / 10 to CEMI.


Can you provide the valuation status for CHEMBIO DIAGNOSTICS INC?

ChartMill assigns a valuation rating of 2 / 10 to CHEMBIO DIAGNOSTICS INC (CEMI). This can be considered as Overvalued.


Can you provide the profitability details for CHEMBIO DIAGNOSTICS INC?

CHEMBIO DIAGNOSTICS INC (CEMI) has a profitability rating of 1 / 10.